Merck (MEX:MRK) Total Equity: MXN828,260 Mil (As of Mar. 2026)


MEX:MRK Merck & Co Inc MEX:MRK
74 GF Score
Price MXN2,199.98
GF Value MXN2,079.60
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Merck Total Equity?

Merck MEX:MRK -2.27% 74 Total Equity is MXN828,260 Mil as of Mar. 2026. GuruFocus rates MEX:MRK with a GF Score™ of 74/100 and a GF Value™ of MXN2,079.60 (Fairly Valued). The stock has 7 warning signs investors should review.

Merck's total equity for the quarter that ended in Mar. 2026 was MXN828,260 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Merck Total Equity Historical Data

* Premium members only.

The historical data trend for Merck's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck Total Equity Chart

Merck Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 784,804.10 897,946.77 638,825.82 967,120.52 948,216.17

Merck Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 990,176.88 923,760.55 952,192.39 948,216.17 828,259.94
MEX:MRK
74GF Score
Merck & Co Inc MEX:MRK
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merck Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Merck's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=2464368.138-1516151.964
=948,216

Merck's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=2320538.001-1492278.057
=828,260

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of MXN828,260 Mil mean?
Merck (MEX:MRK) has a Total Equity of MXN828,260 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Merck and its competitors.
Is Merck's Total Equity too high?
Merck's current Total Equity is MXN828,260 Mil. Overall, Merck has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Merck's Total Equity compare to AMGN and ABBV?
Merck's Total Equity of MXN828,260 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Merck and its competitors. Merck's current Total Equity is MXN828,260 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck stock overvalued right now?
Based on GuruFocus' analysis, Merck (MEX:MRK) is currently considered Fairly Valued. The stock's GF Value™ is MXN2,079.60, compared to a current price of MXN2,199.98 — trading 5.8% above its estimated fair value. The current Total Equity is MXN828,260 Mil. Merck's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Merck (MEX:MRK), the current Total Equity is MXN828,260 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merck (MEX:MRK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of MXN2,199.98 is trading 5.8% above its estimated GF Value™ of MXN2,079.60. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for MEX:MRK:

  • Total Equity: MXN828,260 Mil
  • GF Value™: MXN2,079.60 vs. price of MXN2,199.98 (5.8% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the MEX:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
74GF Score

Get the complete analysis for MEX:MRK

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,199.98
Price
MXN2,079.60
GF Value